Abstract
Rheumatoid arthritis is a chronic auto-immune disease that is characterized by both localized and systemic inflammation of internal organs and joints. Elevated plasma concentrations of pro-inflammatory cytokines, such as interleukin-6 (IL-6), interleukin-1b (IL-1b), tumor necrosis factor- α (TNF-α), and acute phase proteins, are responsible for both localized and systemic inflammation. Rheumatoid arthritis is a disease which is affecting 1–1.5% of the population worldwide and females are more affected than male, with a ratio of 2:1. Rheumatoid arthritis symmetrically affect both side of joints i.e., interphalangeal joints such as the proximal interphalangeal, metacarpophalangeal, and metatarsophalangeal joints of the hands and feet as well as the wrist and ankle. There are number of drugs molecules available for treatment of rheumatoid arthritis which have limited efficiency with serious side effects. After the development of targeted drug delivery system, the panic of adverse effects and toxicity has been reduced for other nontarget body organs. Furthermore, the efficiency of drugs towards target site has also increased. With this review our group tried to discuss various novel strategies available for the treatment of autoimmune disease i.e., rheumatoid arthritis.
Keywords: Folate, Immunotherapy, Monoclonal antibodies, Angiogenesis, Dendritic cells, Tyrosine kinase.
Current Drug Therapy
Title:Emerging Therapeutic Strategies for Rheumatoid Arthritis
Volume: 7 Issue: 3
Author(s): Kavita Rai Gajbhiye, Devendra Kumar Soni and Vandana Soni
Affiliation:
Keywords: Folate, Immunotherapy, Monoclonal antibodies, Angiogenesis, Dendritic cells, Tyrosine kinase.
Abstract: Rheumatoid arthritis is a chronic auto-immune disease that is characterized by both localized and systemic inflammation of internal organs and joints. Elevated plasma concentrations of pro-inflammatory cytokines, such as interleukin-6 (IL-6), interleukin-1b (IL-1b), tumor necrosis factor- α (TNF-α), and acute phase proteins, are responsible for both localized and systemic inflammation. Rheumatoid arthritis is a disease which is affecting 1–1.5% of the population worldwide and females are more affected than male, with a ratio of 2:1. Rheumatoid arthritis symmetrically affect both side of joints i.e., interphalangeal joints such as the proximal interphalangeal, metacarpophalangeal, and metatarsophalangeal joints of the hands and feet as well as the wrist and ankle. There are number of drugs molecules available for treatment of rheumatoid arthritis which have limited efficiency with serious side effects. After the development of targeted drug delivery system, the panic of adverse effects and toxicity has been reduced for other nontarget body organs. Furthermore, the efficiency of drugs towards target site has also increased. With this review our group tried to discuss various novel strategies available for the treatment of autoimmune disease i.e., rheumatoid arthritis.
Export Options
About this article
Cite this article as:
Gajbhiye Rai Kavita, Soni Kumar Devendra and Soni Vandana, Emerging Therapeutic Strategies for Rheumatoid Arthritis, Current Drug Therapy 2012; 7 (3) . https://dx.doi.org/10.2174/157488512803988085
DOI https://dx.doi.org/10.2174/157488512803988085 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial [Hot Topic:Supramolecular Devices for the High-Throughput Screening of Drugs,Nutrients and Metabolites in Postgenomic Era (Part 3) (Guest Editor: Grzegorz Bazylak)]
Combinatorial Chemistry & High Throughput Screening Interleukin-26, An Epitheliotropic T-Cell Cytokine
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Anti-TNF Antibodies in Inflammatory Bowel Disease: Do We Finally Know How it Works?
Current Drug Targets The TOLL-like / Type-I Interferon Pathways as Emerging Therapeutic Targets for Autoimmune Diseases
Drug Design Reviews - Online (Discontinued) Insights into the Role of Fc Gamma Receptors (FcγRs) Genetic Variations in Monoclonal Antibody-Based Anti-Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery COX-2 and the Kidneys
Current Pharmaceutical Design Circumscribing the Conformational Peptide Epitope Landscape
Current Pharmaceutical Design Plasmid DNA Gene Therapy by Electroporation: Principles and Recent Advances
Current Gene Therapy New and Emerging Antiresorptive Treatments in Osteoporosis
Current Drug Safety Fibroblast Activation Protein in Remodeling Tissues
Current Molecular Medicine p38 MAPK: A Potential Target of Chronic Pain
Current Medicinal Chemistry Rheumatological Manifestations in Diabetes Mellitus
Current Diabetes Reviews Serum Cytokine Profile in Alzheimer's Disease Patients After Ingestion of an Antioxidant Beverage
CNS & Neurological Disorders - Drug Targets Circumventing Immune Tolerance Through Epigenetic Modification
Current Pharmaceutical Design Newer Insights in Personalized and Evidence Based Medicine- the Role of MicroRNAs
Current Pharmacogenomics and Personalized Medicine Potential Interaction Between Valproic Acid and Doripenem
Current Drug Safety Novel Insights into the Pathogenesis of Osteoarthritis
Current Rheumatology Reviews Fluorescent Substrates Useful as High Throughput Screening Tools for ADAM9
Combinatorial Chemistry & High Throughput Screening Need for Nutritious Convenience Foods for the Elderly Population: A Review
Current Nutrition & Food Science Heterocyclic Compounds as Anti-Inflammatory Agents
Current Bioactive Compounds